Date Filed | Type | Description |
02/12/2009 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/07/2008 |
SC 13G/A
| BARCLAYS GLOBAL INVESTORS NA reports a 0% stake in MGI PHARMA INC |
02/14/2008 |
SC 13G
| PAULSON & CO INC reports a 8.4% stake in MGI PHARMA, INC. |
02/14/2008 |
SC 13G/A
| SAC CAPITAL ADVISORS LLC reports a 0% stake in MGI PHARMA, INC. |
02/14/2008 |
SC 13G/A
| D. E. Shaw Composite Portfolios, L.L.C. reports a 1.7% stake in MGI PHARMA, Inc. |
02/11/2008 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP LLC reports a 4.3% stake in MGI PHARMA, INC. |
02/05/2008 |
SC 13G
| BARCLAYS GLOBAL INVESTORS NA reports a 5.9% stake in MGI PHARMA INC |
01/28/2008 |
8-K
| Quarterly results |
01/23/2008 |
8-K
| Changes in Control of Registrant, Financial Statements and Exhibits |
01/10/2008 |
SC 13G/A
| WELLINGTON MANAGEMENT CO LLP reports a 4.6% stake in MGI Pharma, Inc. |
01/10/2008 |
SC 13G/A
| FMR CORP reports a 2.3% stake in MGI Pharma Inc |
01/10/2008 |
SC 13G/A
| WESTFIELD CAPITAL MANAGEMENT CO LLC reports a 0% stake in MGI Pharma Inc. |
12/27/2007 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta... |
12/11/2007 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
12/10/2007 |
SC 13G
| SAC CAPITAL ADVISORS LLC reports a 5.8% stake in MGI PHARMA, INC. |
10/26/2007 |
10-Q
| Quarterly Report for the period ended September 30, 2007 |
10/17/2007 |
8-K
| Quarterly results |
10/17/2007 |
TRN
| MGI Pharma Q3 2007 Earnings Call Transcript |
10/12/2007 |
8-K/A
| Cost Associated with Exit or Disposal Activities |
10/10/2007 |
SC 13G/A
| FMR CORP reports a 10.1% stake in MGI PHARMA INC |
09/27/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
08/30/2007 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
07/27/2007 |
10-Q
| Quarterly Report for the period ended June 30, 2007 |
07/18/2007 |
8-K
| Quarterly results |
06/29/2007 |
11-K
| Form 11-K -- Annual report of employee stock purchase, savings and similar plans |
05/10/2007 |
SC 13G/A
| D. E. Shaw Meniscus Portfolios, L.L.C. reports a 5.2% stake in MGI PHARMA, Inc. |
04/27/2007 |
10-Q
| Quarterly Report for the period ended March 31, 2007 |
04/18/2007 |
8-K
| Quarterly results |
03/29/2007 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/01/2007 |
10-K
| Annual Report for the period ended December 31, 2006 |
03/01/2007 |
10-Q/A
| Quarterly Report for the period ended September 30, 2006 [amend] |
03/01/2007 |
10-Q/A
| Quarterly Report for the period ended June 30, 2006 [amend] |
03/01/2007 |
8-K
| Results of Operations and Financial Condition, Non-Reliance on Previously Issued Financial Statements or a Related Audit Repo... |
02/14/2007 |
SC 13G/A
| D. E. Shaw Meniscus Portfolios, L.L.C. reports a 6.4% stake in MGI PHARMA, Inc. |
|